跳至主要内容
临床试验/TCTR20200709009
TCTR20200709009已完成3 期

Efficacy of Single intra-articular 2% Sodium hyaluronate versus Corticosteroid injection in Isolated Patellofemoral Osteoarthritis A Double-Blind, Randomized Controlled Trial

Faculty of medicine,Thammasart University.0 个研究点目标入组 60 人开始时间: 2020年7月9日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Patient diagnosed with Isolated Patellofemoral osteoarthritis
  • (Diagnostic criteria: Patient having anterior knee pain while getting up and walking upstairs, physical examination shows tenderness at the patellofemoral joint line, patellar grinding test positive. And Knee Lateral or patella skyline X-RAY/MRI consists of OA change of the Patellofemoral joint.
  • 2. Persistent anterior knee pain with VAS more than 30/100mm despite the conservative treatment for 3 months.
  • 3. Age 35-80 years.
  • 4. Understandable, Co-operate with treatment and follow-up protocol.

排除标准

  • 1. Patients with moderate to severe tibiofemoral osteoarthritis. (defined as having the radiographic osteoarthritic change with Kellegren and Lawrence classification of grade 3 or 4 of the tibiofemoral joint.)
  • 2. Patient with abnormal Knee Alignment and Knee deformities.
  • 3. Patient with Knee and Patella Instability.
  • 4. Patient with inflammatory joint disease eg. RA, Crystal induced arthritis.
  • 5. Patient with Post Traumatic patellofemoral osteoarthritis.
  • 6. Patient receiving HA or Corticosteroid injection or previous knee surgery for the past 6 months.
  • 7. Patient allergic to HA or Corticosteroid.

研究者

发起方
Faculty of medicine,Thammasart University.

相似试验